39 results
DEF 14A
NAMS
NewAmsterdam Pharma Company NV
9 May 24
Definitive proxy
4:15pm
) for the Annual General Meeting is May 8, 2024 (the “Record Date”). Those who are shareholders of the Company, or who otherwise have voting rights … of the Company, or who otherwise have voting rights and/or meeting rights with respect to shares in the Company’s capital, at the close of business
PRE 14A
NAMS
NewAmsterdam Pharma Company NV
29 Apr 24
Preliminary proxy
5:00pm
) for the Annual General Meeting is May 8, 2024 (the “Record Date”). Those who are shareholders of the Company, or who otherwise have voting rights … of the Company, or who otherwise have voting rights and/or meeting rights with respect to shares in the Company’s capital, at the close of business on the Record
POS AM
NAMS
NewAmsterdam Pharma Company NV
12 Apr 24
Prospectus update (post-effective amendment)
4:15pm
on by shareholders generally, including the appointment of our directors;
there are no cumulative voting rights;
the holders of Ordinary Shares … . The Warrant holders do not have the rights or privileges of holders of Ordinary Shares and any voting rights until they exercise their Warrants and receive
424B3
NAMS
NewAmsterdam Pharma Company NV
12 Mar 24
Prospectus supplement
4:18pm
of our directors;
there are no cumulative voting rights;
the holders of Ordinary Shares are entitled to dividends and other distributions as may … the rights or privileges of holders of Ordinary Shares and any voting rights until they exercise their Warrants and receive Ordinary Shares. After
POS AM
NAMS
NewAmsterdam Pharma Company NV
28 Feb 24
Prospectus update (post-effective amendment)
5:01pm
generally, including the appointment of our directors;
there are no cumulative voting rights;
the holders of Ordinary Shares are entitled to dividends … . The Warrant holders do not have the rights or privileges of holders of Ordinary Shares and any voting rights until they exercise their Warrants
10-K
zol5ksaw5 r7
28 Feb 24
Annual report
8:00am
10-K
EX-4.4
j0b32 w8bgex0y
28 Feb 24
Annual report
8:00am
10-K
EX-10.4
7kfyc4v77
28 Feb 24
Annual report
8:00am
424B5
pue3 9wjr0
15 Feb 24
Prospectus supplement for primary offering
4:15pm
424B5
repzfdo2xmf846
13 Feb 24
Prospectus supplement for primary offering
5:19pm
F-3
4md v0dm95xr2x5ca
7 Dec 23
Shelf registration (foreign)
4:16pm
424B3
7szrq4
15 Aug 23
Prospectus supplement
4:52pm
POS AM
af01i
7 Aug 23
Prospectus update (post-effective amendment)
7:56am
6-K
EX-99.1
yq60cxapb
31 May 23
Current report (foreign)
8:00am
424B3
cu3ew20 1o8km92pao
25 Apr 23
Prospectus supplement
8:14am
POS AM
wm12pzp2i42
17 Apr 23
Prospectus update (post-effective amendment)
9:09am
S-8
EX-99.1
gpjr 3h1qtdyn1nsi
31 Mar 23
Registration of securities for employees
7:36am
S-8
EX-99.2
sm9dhs5jth5ia xtq
31 Mar 23
Registration of securities for employees
7:36am